Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares gapped down prior to trading on Wednesday . The stock had previously closed at $2.22, but opened at $2.02. Ekso Bionics Holdings shares last traded at $1.75, with a volume of 2851800 shares trading hands.
Separately, Zacks Investment Research lowered Ekso Bionics Holdings from a “buy” rating to a “hold” rating in a report on Wednesday, September 20th.
The company has a current ratio of 6.09, a quick ratio of 5.73 and a debt-to-equity ratio of 0.18.
Ekso Bionics Holdings (NASDAQ:EKSO) last posted its earnings results on Wednesday, November 8th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.05). The company had revenue of $1.60 million for the quarter, compared to analyst estimates of $2.40 million. Ekso Bionics Holdings had a negative return on equity of 323.00% and a negative net margin of 343.53%. equities research analysts forecast that Ekso Bionics Holdings, Inc. will post -0.81 EPS for the current fiscal year.
Institutional investors have recently bought and sold shares of the stock. Carl Domino Inc grew its holdings in Ekso Bionics Holdings by 74.7% during the second quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock worth $190,000 after acquiring an additional 35,088 shares during the period. Intellectus Partners LLC grew its holdings in Ekso Bionics Holdings by 5.3% during the second quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock worth $244,000 after acquiring an additional 5,294 shares during the period. National Planning Corp grew its holdings in Ekso Bionics Holdings by 116.2% during the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock worth $537,000 after acquiring an additional 126,000 shares during the period. Finally, Vanguard Group Inc. grew its holdings in Ekso Bionics Holdings by 32.9% during the second quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock worth $1,650,000 after acquiring an additional 176,197 shares during the period. 2.85% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This article was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://sportsperspectives.com/2017/11/17/ekso-bionics-holdings-inc-ekso-shares-gap-down-to-2-02.html.
Ekso Bionics Holdings Company Profile
Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.